Stereotaxis announced that it has received European CE Mark approval for its MAGiC™ ablation catheter, marking a significant step in advancing robotic technology in electrophysiology. Designed for ...

Stereotaxis has announced the publication of initial clinical results for its MAGiC catheter in the Journal of Interventional Cardiac Electrophysiology, marking the first peer-reviewed support for its ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Stereotaxis has won FDA approval for the MAGiC Magnetic Interventional Ablation Catheter. The device is a robotically navigated magnetic ablation catheter designed to perform cardiac ablation ...

Surgical robotics leader Stereotaxis has earned FDA clearance for its MAGiC Sweep catheter, the world’s first robotically navigated high-density electrophysiology mapping catheter. The catheter marks ...

ST. LOUIS, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced that the first patients have ...

ST. LOUIS, March 03, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced FDA regulatory ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

ST. LOUIS, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it ...

ST. LOUIS, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it obtained ...